ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

<p>Abstract</p> <p>Background</p> <p>Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma (ALK-DLBCL) is a rare lymphoma with several clinicopathological differences from ALK-positive anaplastic large cell lymphoma (ALCL). The latest WHO classification of l...

Full description

Bibliographic Details
Main Authors:	Hurtado Fernando, Morales Domingo, Quiñones Pilar, Salas Renzo, Castillo Jorge, Beltran Brady, Riva Luis, Winer Eric
Format:	Article
Language:	English
Published:	BMC 2009-02-01
Series:	Journal of Hematology & Oncology
Online Access:	http://www.jhoonline.org/content/2/1/11

Similar Items

EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
by: Cotrina Esther, et al.
Published: (2009-07-01)

Clinical Significance of Alk-1 Gene Abnormalities in Diffuse Large Cell Lymphoma
by: Korashy L., et al.
Published: (2012-11-01)

Clinical Significance of Alk-1 Gene Abnormalities in Diffuse Large Cell Lymphoma
by: L. Korashy, et al.
Published: (2012-01-01)

Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.
by: Leandro Cerchietti, et al.
Published: (2011-01-01)

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
by: Serena Stadler, et al.
Published: (2018-04-01)

Pathobiology of ALK-negative anaplastic large cell lymphoma
by: Stefano A. Pileri, et al.
Published: (2011-06-01)

Educational Case: ALK-Negative Anaplastic Large Cell Lymphoma
by: Akira Satou MD, PhD, et al.
Published: (2020-01-01)

ALK signaling and target therapy in anaplastic large cell lymphoma
by: Fabrizio eTabbo, et al.
Published: (2012-05-01)

Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: A rare entity
by: Ritesh Sachdev, et al.
Published: (2014-01-01)

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma
by: Vijay Kumar Singh, et al.
Published: (2019-09-01)

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
by: Moinul Haque, et al.
Published: (2019-08-01)

MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA
by: E. V. Chernyshova, et al.
Published: (2017-01-01)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
by: Suzanne D. Turner
Published: (2017-10-01)

ALK Positive Anaplastic Large Cell Lymphoma Presenting as Extensive Bone Involvement
by: Smeeta Gajendra, et al.
Published: (2015-01-01)

Non-Coding RNA Networks in ALK-Positive Anaplastic-Large Cell Lymphoma
by: Steffen Fuchs, et al.
Published: (2019-04-01)

Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma
by: Giulia Arosio, et al.
Published: (2021-09-01)

Investigating the origin and pathogenesis of NPM-ALK driven anaplastic large cell lymphoma
by: Malcolm, Timothy Ian Mark
Published: (2014)

Investigating the contribution of NPM-ALK to epigenetic regulation in anaplastic large cell lymphoma
by: Garland, Gavin David
Published: (2015)

Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience)
by: YuE Vinogradova, et al.
Published: (2019-03-01)

ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas
by: Sergio Pina-Oviedo, et al.
Published: (2021-09-01)

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report
by: Dennis Christoph Harrer, et al.
Published: (2020-10-01)

ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors.
by: Federica Lovisa, et al.
Published: (2015-01-01)

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
by: Michael T. Werner, et al.
Published: (2017-10-01)

Alk (−) anaplastic large cell lymphoma diagnosed by tongue root biopsy: case report
by: F. Yilmaz, et al.
Published: (2020-10-01)

ALK-negative anaplastic large cell lymphoma mimicking a soft tissue sarcoma
by: Rachel Hudacko, et al.
Published: (2011-01-01)

ALK+ Anaplastic large cell lymphoma with extensive cardiac involvement: A rare case report and review of the literature
by: Kaniyappan Nambiyar, et al.
Published: (2021-01-01)

Use of crizotinib for refractory ALK-positive lymphomas
by: L N Shelikhova, et al.
Published: (2017-07-01)

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma
by: Bhawana George, et al.
Published: (2019-07-01)

Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
by: Ritsuko Nakai, et al.
Published: (2019-12-01)

A Rare Case of ALK-Positive Large B-Cell Lymphoma with CD33 Expression
by: Jessica Corean, et al.
Published: (2018-01-01)

ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman
by: Gao KH, et al.
Published: (2016-07-01)

Anaplastic large cell lymphoma ALK-negative clinically mimicking alcoholic hepatitis – a review
by: Fernando Peixoto Ferraz de Campos, et al.
Published: (2013-10-01)

ALK1-Negative Anaplastic Large Cell Lymphoma of the Breast from a Nonprosthesis Cyst
by: Christopher Mulligan, MBBS, et al.
Published: (2014-10-01)

Systemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell Lymphoma
by: Laura S. Lourdes, et al.
Published: (2012-01-01)

ALK-positive anaplastic large cell lymphoma undiagnosed in a patient with tuberculosis: a case report and review of the literature
by: Weerapat Owattanapanich, et al.
Published: (2017-05-01)

Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
by: Iwama E, et al.
Published: (2014-03-01)

Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells
by: Muhammad Wasi Alam, et al.
Published: (2019-07-01)

Systemic ALK‐positive anaplastic large cell lymphoma with bilateral optic neurolymphomatosis resulting in permanent blindness
by: Karan Seegobin, et al.
Published: (2020-12-01)

ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman [Retraction]
by: Gao K, et al.
Published: (2017-12-01)

Systemic ALK-positive anaplastic large cell lymphoma involving implant site: a fortuitous association
by: Mayur Parkhi, et al.
Published: (2021-08-01)